Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 19 studies | 43% ± 19% | |
endothelial cell of lymphatic vessel | 15 studies | 40% ± 15% | |
fibroblast | 14 studies | 30% ± 10% | |
smooth muscle cell | 14 studies | 35% ± 19% | |
endothelial cell | 7 studies | 26% ± 8% | |
type II pneumocyte | 7 studies | 31% ± 14% | |
type I pneumocyte | 5 studies | 30% ± 12% | |
amacrine cell | 5 studies | 29% ± 12% | |
endothelial cell of vascular tree | 5 studies | 41% ± 13% | |
retinal bipolar neuron | 4 studies | 59% ± 25% | |
microglial cell | 4 studies | 23% ± 6% | |
Mueller cell | 4 studies | 36% ± 13% | |
ON-bipolar cell | 3 studies | 52% ± 22% | |
precursor B cell | 3 studies | 26% ± 2% | |
retina horizontal cell | 3 studies | 24% ± 8% | |
rod bipolar cell | 3 studies | 70% ± 22% | |
connective tissue cell | 3 studies | 32% ± 15% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
eye | 6 studies | 29% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 98% | 2928.85 | 565 / 578 | 93% | 40.98 | 1071 / 1155 |
thymus | 100% | 5956.51 | 652 / 653 | 89% | 91.18 | 537 / 605 |
bladder | 71% | 1225.33 | 15 / 21 | 91% | 54.40 | 460 / 504 |
pancreas | 63% | 414.56 | 205 / 328 | 95% | 53.66 | 169 / 178 |
breast | 61% | 863.70 | 279 / 459 | 96% | 50.77 | 1075 / 1118 |
intestine | 68% | 1043.33 | 661 / 966 | 86% | 28.86 | 454 / 527 |
kidney | 90% | 1624.54 | 80 / 89 | 60% | 21.55 | 541 / 901 |
stomach | 47% | 758.29 | 167 / 359 | 80% | 24.48 | 230 / 286 |
brain | 65% | 696.51 | 1717 / 2642 | 60% | 26.89 | 420 / 705 |
adrenal gland | 50% | 613.24 | 128 / 258 | 73% | 99.02 | 167 / 230 |
esophagus | 53% | 591.05 | 770 / 1445 | 68% | 20.78 | 125 / 183 |
uterus | 36% | 291.42 | 61 / 170 | 75% | 33.38 | 345 / 459 |
ovary | 36% | 326.23 | 64 / 180 | 73% | 23.11 | 316 / 430 |
skin | 36% | 351.96 | 659 / 1809 | 64% | 29.20 | 304 / 472 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.65 | 1 / 1 |
lymph node | 0% | 0 | 0 / 0 | 97% | 73.27 | 28 / 29 |
liver | 59% | 684.63 | 134 / 226 | 32% | 15.80 | 128 / 406 |
blood vessel | 85% | 1693.06 | 1129 / 1335 | 0% | 0 | 0 / 0 |
spleen | 84% | 1626.19 | 203 / 241 | 0% | 0 | 0 / 0 |
adipose | 77% | 2517.91 | 926 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 76% | 18.50 | 34 / 45 |
prostate | 42% | 376.21 | 102 / 245 | 29% | 5.84 | 145 / 502 |
heart | 44% | 469.65 | 377 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 25% | 4.32 | 20 / 80 |
peripheral blood | 22% | 882.17 | 205 / 929 | 0% | 0 | 0 / 0 |
muscle | 18% | 262.61 | 141 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007601 | Biological process | visual perception |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0008277 | Biological process | regulation of G protein-coupled receptor signaling pathway |
GO_0043547 | Biological process | positive regulation of GTPase activity |
GO_0009968 | Biological process | negative regulation of signal transduction |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005096 | Molecular function | GTPase activator activity |
GO_0005516 | Molecular function | calmodulin binding |
GO_0005515 | Molecular function | protein binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | RGS16 |
Protein name | Regulator of G-protein signaling 16 (RGS16) (A28-RGS14P) (Retinal-specific RGS) (RGS-r) (hRGS-r) (Retinally abundant regulator of G-protein signaling) |
Synonyms | RGSR |
Description | FUNCTION: Regulates G protein-coupled receptor signaling cascades. Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits, thereby driving them into their inactive GDP-bound form . Plays an important role in the phototransduction cascade by regulating the lifetime and effective concentration of activated transducin alpha. May regulate extra and intracellular mitogenic signals (By similarity). . |
Accessions | O15492 ENST00000367558.6 |